MedTrace Logo

Pilot Study on Metabolic Effects of Fish Peptides and Vitamin D

NCT02668159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2021-07-07

No results posted yet for this study

Summary

The overall goal of this study is to investigate the effects and the mechanisms of action of a fish peptide and vitamin D on glucose metabolism, insulin secretion, and cardiometabolic risk profile in overweight men. Transcriptomic and metabolomic approaches will be used to study the acute physiological effects of fish nutrients and to discover gene/metabolite networks that underlie these effects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish peptide supplement

6 capsules of fish peptide supplement (3g/each) administered prior to one of the OGTT

DIETARY_SUPPLEMENT

Vitamin D supplement

1 tablet of vitamin D3 (1000 UI) administered prior to one of the OGTT

DIETARY_SUPPLEMENT

Fish peptide + Vitamin D3 supplements

6 capsules of fish peptide (3g/each) + 1 tablet of vitamin D3 (1000 UI) administered prior to one of the OGTT

DIETARY_SUPPLEMENT

Placebo

7 tablets of placebos administered prior to one the OGTT

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Laval University

    lead OTHER

Principal Investigators

  • Marie-Claude Vohl · Instute of Nutrition and Functional Foods, Laval University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02668159 on ClinicalTrials.gov